1. Home
  2. IMNM vs ORRF Comparison

IMNM vs ORRF Comparison

Compare IMNM & ORRF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • ORRF
  • Stock Information
  • Founded
  • IMNM 2006
  • ORRF 1919
  • Country
  • IMNM United States
  • ORRF United States
  • Employees
  • IMNM N/A
  • ORRF N/A
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • ORRF Major Banks
  • Sector
  • IMNM Health Care
  • ORRF Finance
  • Exchange
  • IMNM Nasdaq
  • ORRF Nasdaq
  • Market Cap
  • IMNM 748.3M
  • ORRF 608.7M
  • IPO Year
  • IMNM 2020
  • ORRF N/A
  • Fundamental
  • Price
  • IMNM $8.75
  • ORRF $29.85
  • Analyst Decision
  • IMNM Strong Buy
  • ORRF Buy
  • Analyst Count
  • IMNM 5
  • ORRF 3
  • Target Price
  • IMNM $26.40
  • ORRF $34.50
  • AVG Volume (30 Days)
  • IMNM 874.4K
  • ORRF 148.1K
  • Earning Date
  • IMNM 08-11-2025
  • ORRF 07-22-2025
  • Dividend Yield
  • IMNM N/A
  • ORRF 3.48%
  • EPS Growth
  • IMNM N/A
  • ORRF N/A
  • EPS
  • IMNM N/A
  • ORRF 1.84
  • Revenue
  • IMNM $10,938,000.00
  • ORRF $203,869,000.00
  • Revenue This Year
  • IMNM N/A
  • ORRF $22.45
  • Revenue Next Year
  • IMNM $349.38
  • ORRF $3.45
  • P/E Ratio
  • IMNM N/A
  • ORRF $16.20
  • Revenue Growth
  • IMNM N/A
  • ORRF 56.29
  • 52 Week Low
  • IMNM $5.15
  • ORRF $25.08
  • 52 Week High
  • IMNM $16.81
  • ORRF $41.99
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 48.43
  • ORRF 46.31
  • Support Level
  • IMNM $9.02
  • ORRF $29.39
  • Resistance Level
  • IMNM $9.91
  • ORRF $31.12
  • Average True Range (ATR)
  • IMNM 0.55
  • ORRF 0.76
  • MACD
  • IMNM -0.08
  • ORRF -0.12
  • Stochastic Oscillator
  • IMNM 9.37
  • ORRF 21.70

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About ORRF Orrstown Financial Services Inc

Orrstown Financial Services Inc is a holding company engaged in commercial banking and trust business, this involves accepting demand, time, and savings deposits and granting loans. The company is also engaged in lending services for commercial, residential, commercial mortgages, construction, municipal, and various forms of consumer lending, and deposit services that include checking, savings, time, and money market deposits. It also provides investment and brokerage services through its Financial Advisors division. The Company earns fees from its deposit clients for transaction-based account maintenance and overdraft services, It also earns wealth management and investment brokerage fees from its contracts with trusts. The company operates in a segment, namely Community Banking.

Share on Social Networks: